14
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Interferon-α2b Therapy in Low-Activity Hepatitis C: A Pilot Study

, , , , , , , , , , , , & show all
Pages 1256-1260 | Received 11 Jun 1997, Accepted 07 Sep 1997, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A. Tran, F. Longo, D. Ouzan, D. Bianchi, C. Pradier, M. C. Saint-Paul, C. Sattonnet, C. Laffont, S. Dantin, T. Piche, S. Benzaken, P. Rampal. (2000) Effects of 1-Year Interferon-Alpha 2a Treatment in Patients with Chronic Hepatitis C and Persistently Normal Transaminase Activity. Scandinavian Journal of Gastroenterology 35:4, pages 433-437.
Read now

Articles from other publishers (17)

Claudio Puoti, Adriano M. Pellicelli, Mario Romano, Fabrizio Mecenate, Riccardo Guarisco, Giorgio Barbarini, Ettore Mazzoni, Lucia Spilabotti, Lia Bellis, Federica Paglia, Angelo Barlattani, Antonio Picardi, Amerigo Paffetti, Maria Elena Bonaventura, Lorenzo Nosotti, Olga Mitidieri, Orlando Dell' Unto, Roberto Villani, Chiara Dell' Unto, Aldo Morrone & Fabrizio Soccorsi. (2009) Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon α-2a and ribavirin: a multicentric study. Liver International 29:10, pages 1479-1484.
Crossref
Ira M Jacobson, Furqaan Ahmed, Mark W Russo, Edward Lebovics, Douglas T Dieterich, Stephen P Esposito, Nancy Bach, Franklin Klion, Hillel Tobias, Louis Antignano, Robert S Brown, David Gabbaizadeh, Jane Geders & Hulya Levendoglu. (2004) Interferon Alpha-2b and Ribavirin for Patients with Chronic Hepatitis C and Normal ALT. The American Journal of Gastroenterology 99:9, pages 1700-1705.
Crossref
C. Puoti, M. Guido, A. Mangia, M. Persico & D. Prati. (2003) Clinical management of HCV carriers with normal aminotransferase levels. Digestive and Liver Disease 35:5, pages 362-369.
Crossref
Mark W. Russo & Robert S. BrownJrJr. (2003) Patients with chronic hepatitis C who have normal ALT: A role for interferon-based therapy?. Current Hepatitis Reports 2:1, pages 11-16.
Crossref
Nicholas C. TassopoulosIrene VafiadisDimitrios TsantoulasJulia SyrokostaGregory HatzisJohanna K. DelladetsimaMaria DemonakouVana SypsaAngelos E. Hatzakis. (2002) IFN- α 2b Monotherapy in Patients with Chronic Hepatitis C and Persistently Normal or Near Normal Aminotransferase Activity: A Randomized, Controlled Study . Journal of Interferon & Cytokine Research 22:3, pages 365-369.
Crossref
Christophe Hezode & Daniel Dhumeaux. (2002) Hépatite chronique C à transaminases normales de façon répétée. médecine/sciences 18:3, pages 357-361.
Crossref
Samuel S. Lee & Morris Sherman. (2001) Pilot study of interferon-alpha and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values. Journal of Viral Hepatitis 8:3, pages 202-205.
Crossref
Pierre-Edouard Queneau, Florence Osaer, Jean-Pierre Bronowicki, Benedicte Monnot, Gerard Thiefin, Dominique Bettinger, Jean-Pierre Carbillet, Jean-Jacques Raabe, Serge Fratte, Anne Minello-Franza, Solange Bresson-Hadni & Jean-Philippe Miguet. (2001) Treatment of mild chronic hepatitis C with interferon α-2b: results of a multi-centre randomized study in 80 patients. European Journal of Gastroenterology & Hepatology 13:2, pages 143-147.
Crossref
Mark W. Russo & Robert S. BrownJrJr. (2001) Should patients with chronic hepatitis c who have normal alt levels be treated?. Current Gastroenterology Reports 3:1, pages 49-53.
Crossref
H. B. Krarup, J. M. Møller, P. B. Christensen, T. Fuglsang, J. Ingerslev, T. Arnfred & P. H. Madsen. (2008) Haemophilic patients with hepatitis C have higher viral load compared to other well‐defined patient groups. Journal of Viral Hepatitis 7:6, pages 435-439.
Crossref
C. Puoti, R. Castellacci & F. Montagnese. (2000) Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?. Digestive and Liver Disease 32:7, pages 634-643.
Crossref
Prati, Zanella, Zanuso, Vianello, E. Della Torre, Mozzi, Carriero, Zahm, Donato, Colombo & Sirchia. (2000) Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C. Journal of Viral Hepatitis 7:5, pages 352-360.
Crossref
Stuart C. Gordon, Jane W. Fang, Ann L. Silverman, John G. McHutchison & Janice K. Albrecht. (2000) The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C. Hepatology 32:2, pages 400-404.
Crossref
Kondili, Taliani, Tosti, De Bac, Pasquazzi & Mele. (2000) Methodological issues in papers on IFN therapy: time for reappraisal. Journal of Viral Hepatitis 7:3, pages 184-195.
Crossref
John G. McHutchison & Jay H. Hoofnagle. 2000. Hepatitis C. Hepatitis C 203 239 .
Patrick Marcellin, Michèle Martinot, Nathalie Boyer & Stéphane Lévy. (1999) TREATMENT OF HEPATITIS C PATIENTS WITH NORMAL AMINOTRANSFERASES LEVELS. Clinics in Liver Disease 3:4, pages 843-853.
Crossref
Nicholas C. Tassopoulos. (1999) Treatment of patients with chronic hepatitis C and normal ALT levels. Journal of Hepatology 31, pages 193-196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.